Literature DB >> 32953623

Ovarian cancer recurrence update.

Stefano Cianci1.   

Abstract

Entities:  

Year:  2020        PMID： 32953623      PMCID： PMC7475374          DOI： 10.21037/gs-2020-ocr-08

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


× No keyword cloud information.
  7 in total

Review 1.  Surgical management of recurrent ovarian cancer.

Authors:  Mario M Leitao; Dennis S Chi
Journal:  Semin Oncol       Date:  2009-04       Impact factor: 4.929

Review 2.  Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis.

Authors:  Robert E Bristow; Isha Puri; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2008-10-19       Impact factor: 5.482

3.  Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.

Authors:  Roberto Tozzi; Raffaella Giannice; Stefano Cianci; Sarah Tardino; Riccardo Garruto Campanile; Kumar Gubbala; Giorgio Fachechi; Federico Ferrari; Igor Martinek; Hooman Soleymani Majd
Journal:  Gynecol Oncol       Date:  2015-05-21       Impact factor: 5.482

4.  Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  M Petrillo; P De Iaco; S Cianci; M Perrone; B Costantini; C Ronsini; G Scambia; A Fagotti
Journal:  Ann Surg Oncol       Date:  2015-12-29       Impact factor: 5.344

5.  Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations.

Authors:  Gabriella Ferrandina; Francesco Legge; Vanda Salutari; Amelia Paglia; Antonia Testa; Giovanni Scambia
Journal:  Eur J Cancer       Date:  2006-08-09       Impact factor: 9.162

6.  Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.

Authors:  Anna Fagotti; Barbara Costantini; Valerio Gallotta; Stefano Cianci; Carlo Ronsini; Marco Petrillo; Mara Pacciani; Giovanni Scambia; Francesco Fanfani
Journal:  J Minim Invasive Gynecol       Date:  2014-11-26       Impact factor: 4.137

7.  Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial.

Authors:  Chee Khoon Lee; Sarah Lord; Tami Grunewald; Val Gebski; Anne-Claire Hardy-Bessard; Jalid Sehouli; Kathrine Woie; Mark Heywood; Christian Schauer; Ignace Vergote; Giovanni Scambia; Annamaria Ferrero; Philipp Harter; Eric Pujade-Lauraine; Michael Friedlander
Journal:  Gynecol Oncol       Date:  2014-10-02       Impact factor: 5.482
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.